.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 6,641,800

« Back to Dashboard

Summary for Patent: 6,641,800

Title: Pressurized aerosol compositions comprising powdered medicament dispersed in hydrofluoroalkane
Abstract:Pressurized aerosol composition for administration by inhalation comprising a liquefied hydrofluoroalkane, a powdered medicament dispersed therein, and a suspending agent comprising a polymer soluble in the liquefied hydrofluoroalkane which is selected from polymers including recurring amide containing structural units, copolymers of amide containing units and carboxylic acid ester units, polyvinylacetate and acrylic acid/methacrylic acid ester copolymers.
Inventor(s): Mistry; Suresh N (Birstall, GB), Gibson; Mark (Shepshed, GB)
Assignee: Fisons Ltd. (West Malling, GB)
Application Number:09/616,069
Patent Claim Types:
see list of patent claims
Composition; Device; Process;
Patent Metrics:
Source: PatentQuant.com
Field: Pharmaceuticals
Back Citations: 11th percentile
Forward Citations: 0th percentile

No matches for this query

Premature patent expiration for: 6,641,800

Expiration due to failure to pay maintenance fee

Patent Number Expiration Date
6,641,800 November 04, 2015

Foreign Priority and PCT Information for Patent: 6,641,800

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9120396Sep 25, 1991
United Kingdom9120675Sep 28, 1991
United Kingdom9124661Nov 19, 1991

International Patent Family for Patent: 6,641,800

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada2119932► subscribe
China1071832► subscribe
China1050285► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc